Biaryl diacid inhibitors of human s-PLA2 with anti-inflammatory activity

Twenty-four hydrophobic dicarboxylic acids are described which were evaluated as inhibitors of 14 kDa human platelet phospholipase A2 (HP-PLA2). In general, biarylacetic acid derivatives were found to be more active than biaryl acids or biarylpropanoic acids. More potent inhibitors were obtained whe...

Full description

Saved in:
Bibliographic Details
Published inBioorganic & medicinal chemistry Vol. 8; no. 5; pp. 1087 - 1109
Main Authors SPRINGER, D. M, LUH, B.-Y, BRONSON, J. J, MCELHONE, K. E, MANSURI, M. M, GREGOR, K. R, NETTLETON, D. O, STANLEY, P. L, TRAMPOSCH, K. M
Format Journal Article
LanguageEnglish
Published Oxford Elsevier Science 01.05.2000
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Twenty-four hydrophobic dicarboxylic acids are described which were evaluated as inhibitors of 14 kDa human platelet phospholipase A2 (HP-PLA2). In general, biarylacetic acid derivatives were found to be more active than biaryl acids or biarylpropanoic acids. More potent inhibitors were obtained when hydrophobic groups were attached to the biaryl acid nucleus using an olefin linkage as compared to an ether linkage. Compounds with larger hydrophobic groups were usually more potent inhibitors of HP-PLA2. Five of the compounds disclosed in this report (2, 4, 28, 36b and 36i) were found to possess significant anti-inflammatory activity in a phorbol ester induced mouse ear edema model of chronic inflammation.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0968-0896
1464-3391
DOI:10.1016/S0968-0896(00)00047-X